Skip to main content

and
  1. No Access

    Article

    Treatment of patients with refractory myelogenous leukemia with BCOMM [1,3-bis-chloro(2-chloroethyl)-1-nitrosourea (BCNU), oncovin (vincristine), cyclophosphamide, high-dose methotrexate and methyl-glyoxal bis-guanylhydrazone (MGBG)]

    Ten patients with AML refractory to anthracyclines and cytosine arabinoside were treated with vincristine 1.4 mg/m2 and methotrexate (MTX) 2.5 gm/m2 by intravenous (IV) bolus on day 1 [citrovorum factor (CF) resc...

    Terence S. Herman, Brian G. M. Durie in Cancer Chemotherapy and Pharmacology (1982)

  2. No Access

    Article

    Quantitative association between the in vitro human tumor stem cell assay and clinical response to cancer chemotherapy

    Objective methods have been developed to quantitate results of the in vitro human tumor stem cell assay, the degree of the association between the in vitro assay and clinical response as well as the likelihood...

    Thomas E. Moon, Sydney E. Salmon, Carolyn S. White in Cancer Chemotherapy and Pharmacology (1981)